B4GALT7

UniProt ID: Q9UBV7
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

B4GALT7 encodes a 327-residue, manganese-dependent type-II Golgi membrane glycosyltransferase of the GT7 family. Its lumen-facing catalytic domain transfers galactose from UDP-galactose to xylose attached to a serine of a proteoglycan core protein, forming a beta1,4 linkage. This first galactose is the second sugar of the shared tetrasaccharide linker used to assemble chondroitin sulfate, dermatan sulfate, heparan sulfate and heparin proteoglycans. Defective linker synthesis impairs proteoglycan glycanation and extracellular-matrix organization; biallelic pathogenic variants cause a spondylodysplastic Ehlers-Danlos syndrome.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000139 Golgi membrane
IEA
GO_REF:0000117
ACCEPT
Summary: Golgi membrane is the site of the membrane-anchored linker enzyme.
Reason: The type-II membrane enzyme adds the first galactose to the proteoglycan linker at the Golgi. Independent localization and the curated reaction support this compartment; the disease reaction describes disruption of the normal enzyme activity, not relocation of every mutant.
Supporting Evidence:
Reactome:R-HSA-1889981
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-1889981
ACCEPT
Summary: Golgi membrane is the site of the membrane-anchored linker enzyme.
Reason: The type-II membrane enzyme adds the first galactose to the proteoglycan linker at the Golgi. Independent localization and the curated reaction support this compartment; the disease reaction describes disruption of the normal enzyme activity, not relocation of every mutant.
Supporting Evidence:
Reactome:R-HSA-1889981
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-3560804
ACCEPT
Summary: Golgi membrane is the site of the membrane-anchored linker enzyme.
Reason: The type-II membrane enzyme adds the first galactose to the proteoglycan linker at the Golgi. Independent localization and the curated reaction support this compartment; the disease reaction describes disruption of the normal enzyme activity, not relocation of every mutant.
Supporting Evidence:
Reactome:R-HSA-1889981
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
IDA
PMID:24052259
Crystal structures of Ξ²-1,4-galactosyltransferase 7 enzyme r...
MODIFY
Summary: The demonstrated acceptor is xylose on the proteoglycan linker.
Reason: B4GALT7 transfers galactose to xylose in proteoglycan-linker synthesis. The experiments in PMID:24052259 characterize this xylose-directed reaction; GlcNAc-directed B4GALT1 is a comparison. GO:0003831 instead specifies a GlcNAc glycopeptide acceptor. GO:0046525 captures the experimentally supported B4GALT7 activity.
Supporting Evidence:
PMID:10438455
galactosyltransferase activity specific for p-nitrophenyl-beta-D-xylopyranoside.
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
KEEP AS NON CORE
Summary: A curated binary interaction is retained outside the catalytic core.
Reason: The IPI assertion records an interaction with UniProtKB:P53611 in the cited interactome study. This binary interaction does not establish a substrate, stable functional complex, or regulatory mechanism for B4GALT7. It is retained as non-core interaction evidence; the specific supplementary pair record was not independently inspected.
Supporting Evidence:
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
KEEP AS NON CORE
Summary: A curated binary interaction is retained outside the catalytic core.
Reason: The IPI assertion records an interaction with UniProtKB:P60409 in the cited interactome study. This binary interaction does not establish a substrate, stable functional complex, or regulatory mechanism for B4GALT7. It is retained as non-core interaction evidence; the specific supplementary pair record was not independently inspected.
Supporting Evidence:
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
KEEP AS NON CORE
Summary: A curated binary interaction is retained outside the catalytic core.
Reason: The IPI assertion records an interaction with UniProtKB:A8MQ03 in the cited interactome study. This binary interaction does not establish a substrate, stable functional complex, or regulatory mechanism for B4GALT7. It is retained as non-core interaction evidence; the specific supplementary pair record was not independently inspected.
Supporting Evidence:
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
KEEP AS NON CORE
Summary: A curated binary interaction is retained outside the catalytic core.
Reason: The IPI assertion records an interaction with UniProtKB:P53611 in the cited interactome study. This binary interaction does not establish a substrate, stable functional complex, or regulatory mechanism for B4GALT7. It is retained as non-core interaction evidence; the specific supplementary pair record was not independently inspected.
Supporting Evidence:
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
KEEP AS NON CORE
Summary: A curated binary interaction is retained outside the catalytic core.
Reason: The IPI assertion records an interaction with UniProtKB:Q15323 in the cited interactome study. This binary interaction does not establish a substrate, stable functional complex, or regulatory mechanism for B4GALT7. It is retained as non-core interaction evidence; the specific supplementary pair record was not independently inspected.
Supporting Evidence:
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
KEEP AS NON CORE
Summary: A curated binary interaction is retained outside the catalytic core.
Reason: The IPI assertion records an interaction with UniProtKB:Q9NUH8 in the cited interactome study. This binary interaction does not establish a substrate, stable functional complex, or regulatory mechanism for B4GALT7. It is retained as non-core interaction evidence; the specific supplementary pair record was not independently inspected.
Supporting Evidence:
GO:0005794 Golgi apparatus
IBA
GO_REF:0000033
ACCEPT
Summary: Golgi localization is consistent with the curated phylogenetic inference.
Reason: The PAINT Golgi-localization inference agrees with independent localization of the human enzyme and its role in proteoglycan-linker synthesis.
Supporting Evidence:
GO_REF:0000033
GO:0005794 Golgi apparatus
IDA
PMID:10506123
Molecular basis for the progeroid variant of Ehlers-Danlos s...
ACCEPT
Summary: Wild-type human enzyme shows Golgi localization.
Reason: The abstract reports a Golgi staining pattern for wild-type and A186D constructs, whereas L206P is diffusely cytoplasmic. Preserve the wild-type location without assigning all mutant proteins the same distribution. Full microscopy methods were not available.
Supporting Evidence:
GO:0005794 Golgi apparatus
IDA
PMID:34533190
A quantitative study of the Golgi retention of glycosyltrans...
ACCEPT
Summary: The curated Golgi localization agrees with independent human evidence.
Reason: The curated Golgi-localization assertion is corroborated by the independent wild-type localization in PMID:10506123. The available abstract of PMID:34533190 describes a systematic Golgi-retention study; its target-specific constructs and localization measurements were not available for assessment.
Supporting Evidence:
GO:0005975 carbohydrate metabolic process
IEA
GO_REF:0000002
MODIFY
Summary: The broad carbohydrate description can be replaced by the demonstrated linker-building step.
Reason: B4GALT7 transfers galactose to protein-linked xylose during glycosaminoglycan-protein linker synthesis. GO:0120532 identifies that biochemical role more precisely than the broad InterPro-derived carbohydrate-metabolism assignment.
Supporting Evidence:
GO:0006024 glycosaminoglycan biosynthetic process
IDA
PMID:10438455
Human homolog of Caenorhabditis elegans sqv-3 gene is galact...
ACCEPT
Summary: The linker reaction contributes directly to glycosaminoglycan biosynthesis.
Reason: B4GALT7 catalyzes an actual glycosyl-transfer step, rather than merely being required by perturbation. Human enzyme expression rescues defective GAG synthesis and xyloside-priming experiments connect acceptor transfer to chain initiation. The shared linker serves chondroitin/dermatan/heparan sulfate and heparin proteoglycans; this does not extend the reaction to every GAG class.
Supporting Evidence:
PMID:10438455
restored glycosaminoglycan synthesis
GO:0006024 glycosaminoglycan biosynthetic process
IDA
PMID:20809901
Biochemical and thermodynamic characterization of mutated Ξ²1...
ACCEPT
Summary: The linker reaction contributes directly to glycosaminoglycan biosynthesis.
Reason: B4GALT7 catalyzes an actual glycosyl-transfer step, rather than merely being required by perturbation. Human enzyme expression rescues defective GAG synthesis and xyloside-priming experiments connect acceptor transfer to chain initiation. The shared linker serves chondroitin/dermatan/heparan sulfate and heparin proteoglycans; this does not extend the reaction to every GAG class.
Supporting Evidence:
GO:0006024 glycosaminoglycan biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: The linker reaction contributes directly to glycosaminoglycan biosynthesis.
Reason: B4GALT7 catalyzes an actual glycosyl-transfer step, rather than merely being required by perturbation. Human enzyme expression rescues defective GAG synthesis and xyloside-priming experiments connect acceptor transfer to chain initiation. The shared linker serves chondroitin/dermatan/heparan sulfate and heparin proteoglycans; this does not extend the reaction to every GAG class.
Supporting Evidence:
GO:0006029 proteoglycan metabolic process
IMP
PMID:16583246
Defective glycosylation of decorin and biglycan, altered col...
MODIFY
Summary: Specify proteoglycan biosynthesis within the broader metabolic annotation.
Reason: The observed defect is in synthesis of the carbohydrate linker on proteoglycans. Human-enzyme activity and the reduced glycanation of decorin/biglycan support a biosynthetic role; the evidence does not establish a proteoglycan degradation function.
Supporting Evidence:
GO:0006029 proteoglycan metabolic process
TAS
PMID:10473568
Cloning and expression of a proteoglycan UDP-galactose:beta-...
MODIFY
Summary: Specify proteoglycan biosynthesis within the broader metabolic annotation.
Reason: The observed defect is in synthesis of the carbohydrate linker on proteoglycans. Human-enzyme activity and the reduced glycanation of decorin/biglycan support a biosynthetic role; the evidence does not establish a proteoglycan degradation function.
Supporting Evidence:
GO:0006487 protein N-linked glycosylation
IDA
PMID:24052259
Crystal structures of Ξ²-1,4-galactosyltransferase 7 enzyme r...
MODIFY
Summary: The demonstrated process builds the O-serine-linked proteoglycan linker.
Reason: B4GALT7 catalyzes xylose-directed proteoglycan-linker synthesis, as characterized in PMID:24052259. GO:0006487 instead specifies Asn-linked protein glycosylation. N-glycosylation of B4GALT7 itself would not establish that it catalyzes this process; GO:0120532 describes the supported biosynthetic step.
Supporting Evidence:
PMID:10473568
first galactose in the proteoglycan linkage region GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser.
GO:0008378 galactosyltransferase activity
IDA
PMID:10506123
Molecular basis for the progeroid variant of Ehlers-Danlos s...
MODIFY
Summary: Specify xylosylprotein-directed beta1,4-galactose transfer.
Reason: The broad galactosyltransferase label omits the acceptor specificity established by human enzyme expression, product analysis and mutant activity measurements. The more specific term describes UDP-galactose transfer to O-linked xylose. Variant effects remain allele-specific.
GO:0008378 galactosyltransferase activity
IMP
PMID:16583246
Defective glycosylation of decorin and biglycan, altered col...
MODIFY
Summary: Specify xylosylprotein-directed beta1,4-galactose transfer.
Reason: The broad galactosyltransferase label omits the acceptor specificity established by human enzyme expression, product analysis and mutant activity measurements. The more specific term describes UDP-galactose transfer to O-linked xylose. Variant effects remain allele-specific.
GO:0008378 galactosyltransferase activity
TAS
PMID:10473568
Cloning and expression of a proteoglycan UDP-galactose:beta-...
MODIFY
Summary: Specify xylosylprotein-directed beta1,4-galactose transfer.
Reason: The broad galactosyltransferase label omits the acceptor specificity established by human enzyme expression, product analysis and mutant activity measurements. The more specific term describes UDP-galactose transfer to O-linked xylose. Variant effects remain allele-specific.
GO:0016020 membrane
IDA
PMID:10438455
Human homolog of Caenorhabditis elegans sqv-3 gene is galact...
MODIFY
Summary: The supported membrane location can be specified as the Golgi membrane.
Reason: The cloning study identifies a type-II membrane enzyme, and independent localization places wild-type B4GALT7 at the Golgi. Together these data support Golgi membrane localization. They do not independently resolve a particular Golgi cisterna.
Proposed replacements: Golgi membrane
Supporting Evidence:
file:human/B4GALT7/B4GALT7-uniprot.txt
GO:0016757 glycosyltransferase activity
IEA
GO_REF:0000002
MODIFY
Summary: Replace the broad glycosyltransferase category with the demonstrated reaction.
Reason: The transfer uses UDP-galactose as donor and protein-linked xylose as acceptor, with a beta1,4 linkage. This experimentally established specificity refines the broad InterPro assignment.
Supporting Evidence:
GO:0030145 manganese ion binding
IDA
PMID:24052259
Crystal structures of Ξ²-1,4-galactosyltransferase 7 enzyme r...
ACCEPT
Summary: Manganese is part of the catalytic cofactor environment.
Reason: Human catalytic-domain crystal structures contain Mn and UDP in the active-site pocket. This supports enzyme-associated manganese binding; it is integrated into the glycosyltransferase core and does not imply an independent metal-homeostasis role.
Supporting Evidence:
file:human/B4GALT7/B4GALT7-uniprot.txt
Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
GO:0030166 proteoglycan biosynthetic process
IBA
GO_REF:0000033
ACCEPT
Summary: The curated phylogenetic annotation matches the direct biosynthetic reaction.
Reason: The PAINT proteoglycan-biosynthesis inference is corroborated by human enzyme expression and product analysis showing galactose addition to the proteoglycan linker.
Supporting Evidence:
GO_REF:0000033
GO:0032580 Golgi cisterna membrane
IEA
GO_REF:0000044
ACCEPT
Summary: Golgi cisterna membrane is a supported enzyme location.
Reason: The UniProt subcellular-location mapping is consistent with type-II topology and independent Golgi localization. The luminal orientation follows the annotated topology; experimental staining alone does not establish every membrane boundary.
Supporting Evidence:
file:human/B4GALT7/B4GALT7-uniprot.txt
GO:0036211 protein modification process
TAS
PMID:10473568
Cloning and expression of a proteoglycan UDP-galactose:beta-...
MODIFY
Summary: Specify synthesis of the protein-linked glycosaminoglycan linker.
Reason: The cited expression study identifies galactose addition to xylose attached to a proteoglycan core protein. Glycosaminoglycan-protein linkage-region biosynthesis describes this demonstrated role more precisely than general protein modification.
Supporting Evidence:
GO:0046525 xylosylprotein 4-beta-galactosyltransferase activity
EXP
PMID:24052259
Crystal structures of Ξ²-1,4-galactosyltransferase 7 enzyme r...
ACCEPT
Summary: B4GALT7 catalyzes the xylose-directed first galactose addition.
Reason: The specific term matches the human enzyme reaction: UDP-galactose donates galactose to O-linked xylose, forming the first galactose of the proteoglycan linker. Human expression, product analysis and acceptor-binding assays support the assignment. The structural study distinguishes human catalytic-domain structures from the Drosophila D211N donor/acceptor complex; the latter is not presented as human wild-type ternary crystallography.
GO:0046525 xylosylprotein 4-beta-galactosyltransferase activity
IBA
GO_REF:0000033
ACCEPT
Summary: B4GALT7 catalyzes the xylose-directed first galactose addition.
Reason: The PAINT activity inference agrees with the human enzyme reaction: UDP-galactose donates galactose to O-linked xylose, forming the first galactose of the proteoglycan linker. Human expression, product analysis and acceptor-binding assays independently support the assignment.
Supporting Evidence:
GO_REF:0000033
GO:0046525 xylosylprotein 4-beta-galactosyltransferase activity
IDA
PMID:10438455
Human homolog of Caenorhabditis elegans sqv-3 gene is galact...
ACCEPT
Summary: B4GALT7 catalyzes the xylose-directed first galactose addition.
Reason: The specific term matches the human enzyme reaction: UDP-galactose donates galactose to O-linked xylose, forming the first galactose of the proteoglycan linker. Human expression, product analysis and acceptor-binding assays support the assignment.
Supporting Evidence:
GO:0046525 xylosylprotein 4-beta-galactosyltransferase activity
IDA
PMID:20809901
Biochemical and thermodynamic characterization of mutated Ξ²1...
ACCEPT
Summary: B4GALT7 catalyzes the xylose-directed first galactose addition.
Reason: The specific term matches the human enzyme reaction: UDP-galactose donates galactose to O-linked xylose, forming the first galactose of the proteoglycan linker. Human expression, product analysis and acceptor-binding assays support the assignment.
Supporting Evidence:
GO:0046525 xylosylprotein 4-beta-galactosyltransferase activity
IEA
GO_REF:0000120
ACCEPT
Summary: B4GALT7 catalyzes the xylose-directed first galactose addition.
Reason: The specific term matches the human enzyme reaction: UDP-galactose donates galactose to O-linked xylose, forming the first galactose of the proteoglycan linker. Human expression, product analysis and acceptor-binding assays support the assignment.
Supporting Evidence:
GO_REF:0000120
GO:0046525 xylosylprotein 4-beta-galactosyltransferase activity
TAS
Reactome:R-HSA-1889981
ACCEPT
Summary: B4GALT7 catalyzes the xylose-directed first galactose addition.
Reason: The specific term matches the human enzyme reaction: UDP-galactose donates galactose to O-linked xylose, forming the first galactose of the proteoglycan linker. Human expression, product analysis and acceptor-binding assays support the assignment.
Supporting Evidence:
Reactome:R-HSA-1889981
GO:0046525 xylosylprotein 4-beta-galactosyltransferase activity
TAS
Reactome:R-HSA-3560804
ACCEPT
Summary: B4GALT7 catalyzes the xylose-directed first galactose addition.
Reason: The specific term matches the human enzyme reaction: UDP-galactose donates galactose to O-linked xylose, forming the first galactose of the proteoglycan linker. Human expression, product analysis and acceptor-binding assays support the assignment. The disease reaction reports disruption of this normal activity; A186D and R270C can retain activity and should not be summarized as universally null.
Supporting Evidence:
Reactome:R-HSA-3560804
GO:0048147 negative regulation of fibroblast proliferation
IMP
PMID:16583246
Defective glycosylation of decorin and biglycan, altered col...
UNDECIDED
Summary: The direction of the fibroblast-proliferation assertion remains unresolved.
Reason: The abstract of PMID:16583246 reports reduced proliferation in R270C patient fibroblasts with reduced enzyme activity. The associated cellular abnormalities make it unclear whether this reflects a specific regulatory role or secondary cell dysfunction. The unavailable full paper is needed to resolve the direction of the experimental proliferation annotation.
Supporting Evidence:
PMID:16583246
decreased proliferation rates.
GO:0097435 supramolecular fiber organization
IMP
PMID:16583246
Defective glycosylation of decorin and biglycan, altered col...
KEEP AS NON CORE
Summary: Altered collagen fibrils are a downstream phenotype of deficient proteoglycan glycanation.
Reason: Patient fibroblasts display abnormal collagen suprastructures along with defective decorin/biglycan glycanation. Retain the IMP phenotype outside the enzyme core; it does not demonstrate that B4GALT7 itself is a collagen-assembly scaffold or extracellular fibril component.
Supporting Evidence:
PMID:16583246
the collagen suprastructures were altered
GO:0120532 glycosaminoglycan-protein linkage region biosynthetic process
TAS
Reactome:R-HSA-1971475
ACCEPT
Summary: The enzyme catalyzes the second sugar-addition step of the common proteoglycan linker.
Reason: B4GALT7 adds the first galactose to xylose on a core-protein serine, contributing directly to the linker used for chondroitin/dermatan/heparan sulfate or heparin chains. The subsequent galactose and glucuronate additions are performed by other enzymes.
Supporting Evidence:
Reactome:R-HSA-1971475

Core Functions

Catalyzes manganese-dependent transfer of galactose from UDP-galactose to protein-linked xylose, forming the first galactose of the proteoglycan tetrasaccharide linker. The type-II membrane enzyme acts on the luminal side of Golgi cisternae.

Supporting Evidence:

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: Which full-text experiment underlies the negative-regulation-of-fibroblast-proliferation annotation from PMID:16583246, given the abstract reports reduced proliferation in the deficient cells?

Q: Should the GlcNAc-specific activity and N-linked glycosylation assertions citing PMID:24052259, and the GlcNAc ligand label in the raw UniProt binding-site feature, be reconciled with the demonstrated xylose-specific proteoglycan-linker reaction?

Q: How do partial-activity B4GALT7 alleles alter linker occupancy and the different downstream proteoglycan classes in human connective tissues?

πŸ“š Additional Documentation

Notes

(B4GALT7-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)